The Evaluation of Benzodiazepine Substances and Other Depressants, Drug Discrimination Assay
ID: 15DDHQ23Q00000149Type: Solicitation
Overview

Buyer

JUSTICE, DEPARTMENT OFDRUG ENFORCEMENT ADMINISTRATIONHEADQUATERSSPRINGFIELD, VA, 22152, USA

PSC

SUPPORT- PROFESSIONAL: OPERATIONS RESEARCH/QUANTITATIVE ANALYSIS (R405)

Original Source

https://sam.gov/opp/df8694eb23f54f14a47906cb83f12b4a/view
Timeline
  1. 1
    Posted Sep 13, 2023 9:17 PM
  2. 2
    Updated Oct 10, 2023 9:27 PM
  3. 3
    Due Oct 20, 2023 2:00 PM
Description

The Justice Department of the Drug Enforcement Administration (DEA) is soliciting for the evaluation of Benzodiazepine substances and other depressants through a drug discrimination assay. This assay is typically used to determine the effects and characteristics of these substances, aiding in the identification and classification of drugs. The place of performance for this procurement is in Virginia (VA), USA, with a specific zip code of 22152. For any inquiries or submissions, the primary contact is Darrell Goodwin (darrell.goodwin@dea.gov) and the secondary contact is Nanaesi Amoo (nanaesi.amoo@dea.gov). The deadline for offers/quotations is extended to October 20, 2023, at 10:00 A.M.

Point(s) of Contact
Darrell Goodwin
darrell.goodwin@dea.gov
Nanaesi Amoo
nanaesi.amoo@dea.gov
Lifecycle
Title
Type
The Evaluation of Benzodiazepine Substances and Other Depressants, Drug Discrimination Assay
Currently viewing
Solicitation
Similar Opportunities
Warranty Extension
Active
Justice, Department Of
The Drug Enforcement Administration (DEA) plans to award a sole-source procurement contract to JSI Telecom Inc. for a one-year warranty extension. The agency seeks to negotiate a firm fixed-priced purchase order. Per FAR 5.207(c)(16)(ii), the DEA invites vendors to submit capability statements if they can meet the required terms. The agency will consider these submissions but retains discretion on whether to open the procurement to competition. The attached justification further explains this decision. The closing date for submitting capability statements is July 30, 2024, at 10:00 AM Eastern Standard Time. Interested vendors should send their submissions electronically to Sonya.L.Maxwell@dea.gov. Please note that this is not a request for competitive quotations, and there is no RFQ available. Vendors are advised that the NAICS Code for this requirement is 334290. For further clarification, vendors may contact Sonya Maxwell at the provided email address.
Satellite Technology
Active
Justice, Department Of
The Drug Enforcement Administration (DEA) is considering awarding a sole-source contract to Horizon Technologies for satellite-based technology. The agency seeks capability statements from vendors who can meet its requirements in this area. The DEA's focus is on acquiring satellite technology solutions and it intends to issue a firm-fixed price purchase order. Vendors interested in this opportunity must submit their capability statements by the closing date of August 8, 2024, at 10:00 a.m. EST. to Kenny.J.Douangmala@dea.gov. The agency emphasizes that this is not a request for competitive quotations, and it reserves the discretion to determine whether to proceed with a competitive acquisition. No RFQ is available currently. Per the provided NAICS code, this opportunity is categorized under Satellite Telecommunications, with a business size standard of 1,250 employees. For reference, the associated NAICS industry is Radio and Television Broadcasting, and Wireless Communications Equipment Manufacturing. The primary point of contact for any clarifications or questions is Kenny J. Douangmala at the email address mentioned above.
Medical Surveillance
Active
Justice, Department Of
Solicitation from the Department of Justice, Drug Enforcement Administration (DEA) is seeking Medical Surveillance services. Medical Surveillance is typically used for monitoring the health and well-being of individuals, particularly in high-risk environments or occupations. The DEA is looking for a provider to support their medical surveillance program. For more information, refer to the attached RFP_15DDHQ24R00000031. For any inquiries, contact Sherman Green at sherman.green@dea.gov.
Drug Demand Reduction Program (DDRP) Specimen Collection Services
Active
Dept Of Defense
Sources Sought DEPT OF DEFENSE Drug Demand Reduction Program (DDRP) Specimen Collection Services are being procured by DEPT OF THE ARMY, W39L USA NG READINESS CENTER. This service falls under the SUPPORT- PROFESSIONAL: OTHER industry with PSC code R499. The place of performance for this service is Arlington, VA (zip code 22204), USA. The primary contact for this procurement is Alvaro Pineda, who can be reached at alvaro.l.pineda.civ@army.mil or 7036071218. The description of the service can be found in the attached document titled "Drug Demand Reduction Program".
Dextroamphetamine/Amphetamine National Contract
Active
Dept Of Defense
Special Notice DEPT OF DEFENSE Dextroamphetamine/Amphetamine National Contract is being modified to change the address for Acetris. This contract is related to the procurement of medical and surgical instruments, equipment, and supplies. The place of performance for this contract is Monmouth Junction, NJ 08852, USA. For more information, please contact Denise Taubman at denise.taubman@dla.mil or 215-737-8677.